Today: 19 May 2026
Browse Category

EPA:DSY 16 August 2025 - 12 November 2025

Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Paris Stocks Climb as CAC 40 Nears Record; Edenred Sinks on Brazil Fee CapFrance’s blue‑chip index extends gains; luxury and banks advance while meal‑voucher giant tumbles after Brasília’s decree

The CAC 40 rose about 1% to 8,240 in early Paris trading Wednesday, nearing its October record high. Edenred shares dropped 9% after Brazil capped merchant fees and sped up voucher settlements, hitting earnings prospects. Gains were led by luxury and financial stocks, while STMicroelectronics and Dassault Systèmes edged lower. France’s annual inflation slowed to 1.0% in October, with ECB rates unchanged.
12 November 2025
······
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

CAC 40 Near Record High, Defies Moody’s Warning as Luxury Stocks Rally

France’s CAC 40 index held near 8,230 points Monday, flat and just below last week’s record. Moody’s cut France’s outlook to “negative,” but markets were unmoved. Kering surged 9% last week after better-than-feared sales, while Dassault Systèmes and STMicroelectronics dropped over 13% on weak guidance. The CAC 40 is up about 10% year-to-date.
27 October 2025
········
Billion-Dollar Deals, AI Shakeups & Record Highs – Global Business News Roundup (Aug 15–16, 2025)

Billion-Dollar Deals, AI Shakeups & Record Highs – Global Business News Roundup (Aug 15–16, 2025)

The Dow Jones hit an intraday record and closed up 0.08% Friday; the S&P 500 fell 0.3% and Nasdaq dropped 0.4%. U.S. 10-year Treasury yields climbed to 4.32% as traders anticipated Fed rate cuts, with San Francisco Fed President Mary Daly signaling two cuts this year. Gold neared record highs at $3,340 per ounce. Bitcoin briefly touched a record $124,500 before falling back to $117,000.
16 August 2025
······

Stock Market Today

  • CNBC's 2026 Disruptor 50 Firms Signal IPO Market Interest
    May 19, 2026, 2:24 PM EDT. CNBC's 2026 Disruptor 50 list highlights innovative companies increasingly eyeing the initial public offering (IPO) market as a route for growth and capital. The annual list, compiled by CNBC's Julia Boorstin, features emerging companies disrupting industries with technology and business model innovations. Many firms are preparing to tap public markets, signaling renewed activity in IPOs as they seek to fund expansion in a volatile environment. The list underscores a trend of disruptors leveraging the equity market to scale their operations amid evolving economic conditions.

Latest articles

Amazon Stock Drops, But the Bigger $200 Billion AI Question Isn’t Going Away

Amazon Stock Drops, But the Bigger $200 Billion AI Question Isn’t Going Away

19 May 2026
NEW YORK, May 19, 2026, 14:06 (EDT) Amazon.com shares fell about 2.3% to $258.73 in Tuesday afternoon trading, slipping harder than broad market proxies as investors cut exposure to large technology stocks ahead of Nvidia’s results. The stock’s market value stood at about $2.81 trillion, still large enough to keep the $3 trillion question in view but no longer a one-way trade. That is why the move matters now. Amazon’s share price is no longer just a retail story; it is a wager that Amazon Web Services, its cloud-computing arm, can turn heavy artificial-intelligence spending into durable revenue before investors
Astera Labs Moves Higher as Wall Street Eyes Next AI Bottleneck

Astera Labs Moves Higher as Wall Street Eyes Next AI Bottleneck

19 May 2026
Astera Labs shares surged 15.2% to $248.36 Tuesday after Evercore ISI raised its price target and management highlighted rising AI data-center demand. CEO Jitendra Mohan said revenue grew from $65 million at its 2024 IPO to $308 million last quarter. The company’s market value neared $45 billion, with shares trading at about 168 times earnings. One customer accounted for over 70% of projected 2025 revenue.
Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Go toTop